Imidafenacin

咪达那新

Report date: 2026/02/02 10:55:03
NME

Base Information

Drug NameImidafenacin
Drug Alias Name咪非那新imidafenacinumimidafenacina咪达那辛Uritos +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Incontinence, UrgeUrinary IncontinenceUrination Disorders +[4] 
Global Approved IndicationsUrinary Incontinence, UrgeUrinary IncontinenceUrinary Bladder, Overactive
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2007/04/18
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKyorin Holdings IncOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Holdings IncTianjin Hankang Pharmaceutical & Biotechnology Company LtdNanjing Haina Medicine Technology Co Ltd
Inactive CompaniesKyorin Pharmaceutical Co LtdOno Pharmaceutical Co Ltd
Active IndicationsUrinary Incontinence, UrgeUrinary IncontinenceUrination Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeG04BD
Related LinksWikipediaDrugBankKEGG